glp 1 and restless leg syndrome Potential Use of GLP-1 GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Association of GLP-1 Receptor Agonist

For more information, visit SCAI 2025 Scientific Sessions | SCAI

Insulin resistance in adolescents and youth with type 1 diabetes: A review of problems and solutions

The 6-week escalation protocol This modified schedule takes 24 weeks to reach the full 12mg maintenance dose instead of 16 weeks

Effects of Glucagon Like Peptide-1 Receptor Agonists on Endocrine Metabolism Interestingly, GLP-1RAs not only exert a protective effect on the nervous and cardiovascular systems, but also exhibit a regulatory effect on metabolism

His approach goes beyond medication by integrating nutrition, exercise, and accountability to help patients achieve lasting results

The concern historically centered on delayed gastric emptying causing nausea or obstruction, but modern dosing protocols and patient selection have minimized these risks